Bethany Davis
Psychiatry · Atlanta, GANPI 1881763001
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (55.1%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Janssen Research & Development, LLC at 28.3% of the total. Among psychiatry clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 50 payments — averaging $157.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Research & Development, LLC$2K
- Neurocrine Biosciences, Inc.$2K
- AbbVie$2K
- Avanir Pharmaceuticals, Inc.$1K
- E.r. Squibb & Sons, L.L.C.$195
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$129
- plus $182 from 5 others
Across 777 payments — averaging $5673.42 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$1.1M
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$702K
- E.r. Squibb & Sons, L.L.C.$631K
- Boehringer Ingelheim$607K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$332K
- Sage Therapeutics, LLC$211K
- plus $809K from 18 others
What the payments were for
- Consulting fees$1,80023%
- Travel & lodging$4,34755%
- Food & beverage$1,73522%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Research & Development, LLC | 13 | $2,232 |
| Neurocrine Biosciences, Inc. | 14 | $2,040 |
| AbbVie | 1 | $1,800 |
| Avanir Pharmaceuticals, Inc. | 11 | $1,304 |
| E.r. Squibb & Sons, L.L.C. | 1 | $195 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $129 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $80 |
| Lundbeck LLC | 3 | $53 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Stryker | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$1,800
How this compares
$7,882 in reported general payments places this provider in the 90th percentile of 900 psychiatry providers in Georgia.
Other psychiatry in Atlanta
- David PurselleAtlanta$307K
- Michael BurkeAtlanta$217K
- Bryon EvansAtlanta$211K
- Kerry ResslerAtlanta$196K
- Patricio Riva PosseAtlanta$122K
- Ray HorwitzAtlanta$64K
- Boadie DunlopAtlanta$61K
- Zohaib HaqueAtlanta$49K
- Raymond KotwickiAtlanta$44K
- Joseph BergerAtlanta$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.